Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

anti-ribonucleoprotein antibody ATRC-101

An engineered, human immunoglobulin (Ig) G1 monoclonal antibody directed against a ribonucleoprotein (RNP) complex, with potential immunostimulating and antineoplastic activities. Upon administration, anti-RNP antibody ATRC-101 targets and binds to its RNP complex antigen on tumor cells. This may activate the innate immune system, change the local tumor microenvironment (TME) and promote T-cell-mediated killing of tumor cells. The tumor-restricted RNP complex is expressed in a variety of tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-RNP antibody ATRC-101
Code name:ATRC 101
ATRC-101
ATRC101
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search